- Home
- XPO vs FMS Comparison
XPO vs FMS Comparison
Compare XPO & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPO
- FMS
- Stock Information
- Founded
- XPO 2000
- FMS 1996
- Country
- XPO United States
- FMS Germany
- Employees
- XPO N/A
- FMS N/A
- Industry
- XPO Transportation Services
- FMS Misc Health and Biotechnology Services
- Sector
- XPO Consumer Discretionary
- FMS Health Care
- Exchange
- XPO Nasdaq
- FMS Nasdaq
- Market Cap
- XPO 16.0B
- FMS 14.1B
- IPO Year
- XPO N/A
- FMS 1996
- Fundamental
- Price
- XPO $134.08
- FMS $23.40
- Analyst Decision
- XPO Strong Buy
- FMS Sell
- Analyst Count
- XPO 18
- FMS 2
- Target Price
- XPO $145.61
- FMS $30.00
- AVG Volume (30 Days)
- XPO 1.4M
- FMS 486.5K
- Earning Date
- XPO 10-30-2025
- FMS 11-04-2025
- Dividend Yield
- XPO N/A
- FMS 2.44%
- EPS Growth
- XPO N/A
- FMS 8.40
- EPS
- XPO 2.78
- FMS 2.86
- Revenue
- XPO $8,068,000,000.00
- FMS $23,046,819,198.00
- Revenue This Year
- XPO $1.30
- FMS $1.75
- Revenue Next Year
- XPO $3.90
- FMS $3.01
- P/E Ratio
- XPO $48.11
- FMS $16.08
- Revenue Growth
- XPO N/A
- FMS 2.10
- 52 Week Low
- XPO $85.06
- FMS $21.32
- 52 Week High
- XPO $161.00
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- XPO 49.41
- FMS 26.24
- Support Level
- XPO $136.38
- FMS $23.61
- Resistance Level
- XPO $142.03
- FMS $24.17
- Average True Range (ATR)
- XPO 5.68
- FMS 0.40
- MACD
- XPO -0.08
- FMS -0.29
- Stochastic Oscillator
- XPO 54.69
- FMS 0.79
About XPO XPO Inc.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.